Skip to content

Effectiveness of Robotic Assisted Gait Training in Children With Cerebral Palsy

Effectiveness of Robotic Assisted Gait Training in Children With Cerebral Palsy: A Randomized Controlled Clinical Trial Including 3D Gait Analysis

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00887848
Acronym
PeLoGAIT
Enrollment
16
Registered
2009-04-24
Start date
2009-10-05
Completion date
2017-08-14
Last updated
2018-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Keywords

Child, Robotic-assisted treadmill training, Rehabilitation

Brief summary

The purpose of the study is to investigate the effectiveness of robotic-assisted locomotor therapy on improvements of functional gait parameters in ambulatory children with cerebral palsy.

Detailed description

Within a randomized controlled design the effects of robotic-assisted locomotor training (15 sessions within 5 weeks) will be examined in a sample of 34 children with cerebral palsy. Children will be randomly assigned to an intervention or waiting list group. Assessments will be performed at baseline, in week 6 as well as in week 12. The intervention is provided to the waiting list group after the assessment in week 6.

Interventions

15 sessions of Lokomat training within 5 weeks (3 trainings/week)

Sponsors

Reha Rheinfelden
CollaboratorOTHER
University Children's Hospital, Zurich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Bilateral spastic cerebral palsy * Gross Motor Function Classification Scale (GMFCS) II-IV

Exclusion criteria

* Prior orthopedic surgery on the lower extremity or the trunk (\<6 months) * Prior neurosurgical interventions (\<6 months) * Significant mental retardation * Severe contractures * Prior Lokomat training (\<6 months)

Design outcomes

Primary

MeasureTime frame
GMFM-66, section Eweek 0, week 6, week 12

Secondary

MeasureTime frame
GMFM-66, section Dweek 0, week 6, week 12
Gait speedweek 0, week 6, week 12
6-minute walk testweek 0, week 6, week 12
3D gait analysisweek 0, week 6

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026